The Economic Impact of Single-Enantiomer Drugs
In the pharmaceutical business, a "Chiral Switch" is a strategic move where a company develops a single-enantiomer version of a drug that was previously sold as a mixture. A classic example is the allergy medication cetirizine being "switched" to levocetirizine. This move can provide better patient outcomes, fewer side effects, and, crucially for the company, a new patent that protects the...
0 Commenti 0 condivisioni 573 Views 0 Anteprima